What does Visional do?
Visional's core business is BizReach, a direct-recruiting platform for professional and management-class hiring. Companies and headhunters pay to search candidate profiles and send scout messages. Registered professionals use the platform to receive career opportunities. The model repeats when employers keep hiring, recruiters keep using the database, and candidates continue responding to outreach. The investor debate is whether BizReach can keep growing while hiring demand is softer and investment in HRMOS, Internal BizReach, and Incubation keeps margins below the prior peak. The key checks are BizReach growth, organic HRMOS ARR growth, and whether group operating margin stabilizes as investment continues.
What has driven the stock over the past two years?
Visional declined −7% while TOPIX returned +49% over the same period. The issue was not broad market beta. Investors repriced Visional's own disclosures: BizReach remained the earnings engine, but hiring-demand sensitivity, HRMOS growth quality, Incubation losses, and margin investment became harder to ignore.
A · APR–AUG 2025 · +67% BizReach is Visional's core business. Companies and headhunters pay to search candidate profiles and send scout messages to potential hires. The database matters only if enough qualified professionals keep profiles active and respond to outreach, and revenue repeats when those recruiters keep hiring through the platform. Alongside this core engine, investors were also watching whether HRMOS could turn profitable after three years of investment and whether spending on Internal BizReach and Incubation would stay controlled. In Q3 FY7/25 (June 2025), BizReach still grew +19% YoY with 42.7% segment OPM, while HRMOS turned profitable on a YTD basis with ARR at ¥8.95bn. Those disclosures supported the rally to ¥12,310 in August 2025 and a valuation of about ~14x forward EV/EBIT, with the market assuming the FY7/25 full-year print would confirm both growth and improving multi-engine economics.
B · AUG 2025 – FEB 2026 · −48% The reversal was not driven by a headline miss. The FY7/25 full-year release in September was solid and FY7/26 guidance was raised. The pressure came from how the raised guide was built: management said operating profit would lag sales growth because investment was being front-loaded into Internal BizReach, Thinkings/sonar ATS integration, and Incubation. By the Q1 FY7/26 release in December, the market's concern shifted from growth to margin quality. Two concerns then drove the de-rating. First, investors could not separate organic HRMOS profitability from sonar ATS consolidation because the split was not disclosed in detail. Second, Japan domestic hiring sentiment softened through Q4-CY25 on the BOJ rate path, and BizReach's exposure to enterprise hiring confidence was repriced.
ALPHA vs BETA This drawdown looks company-specific, not sector-driven. Over the same 24 months, Visional fell −7% while TOPIX rose +49%, a 56-point underperformance. That gap suggests investors were not simply pricing a broad HR Tech cycle. The larger reset was the multiple investors were willing to pay when capital-efficiency disclosure stayed incomplete, especially around organic-versus-consolidated growth quality.
C · MAR 2026 · +16% OFF FLOOR The Q2 FY7/26 release on 17 March eased the worst-case view: 2Q YTD sales were ¥46.61bn (+26.2% YoY), HR Tech segment OPM held at 33%, HRMOS was profitable on both YTD and quarterly bases, ARR remained ¥8.95bn, and full-year guidance was unchanged. The stock rebounded +16% from the ¥6,347 trough. That move restored confidence in operating momentum, but not in valuation. The remaining gap from today's ¥7,337 to the August peak is mainly a disclosure and quality-of-growth question, not a pure earnings question. Until the market can clearly separate organic HRMOS profitability from M&A contribution, the stock is likely to trade closer to the 8x EV/EBIT zone than the 14x zone.
What are investors debating now?
Three open questions surface in the company's recent quarterly disclosures and in the IR briefing Q&A. Each one settles a different part of the multiple.
What could change over the next twelve months?
Three disclosure or capital-policy levers visible in the filings. Each could reweight the multiple without requiring higher earnings.
What has to be true for the stock to work from here?
Three internally-consistent scenarios across the next four quarters. Each describes a different set of disclosure and operating outcomes — no single scenario is forecast; they are analytical bookends.
- Organic HRMOS ARR growth at Q3 lands below 12% YoY after consolidation back-out.
- FY7/26 guidance revised to group OPM ≤ 22% on Incubation spend.
- BizReach revenue growth below +10% YoY for two consecutive quarters.
- No buyback signal at Q4 / full-year release.
- Q3 release includes organic HRMOS ARR growth in the 18–25% YoY range.
- Group OPM holds at 24–26% for FY7/26 with the engine still funded.
- At least one quarter of Internal BizReach KPI disclosure by year-end.
- Net cash position acknowledged in capital-allocation language at full-year result.
- Organic HRMOS ARR growth disclosed at ≥ 25% YoY, sonar consolidation broken out.
- Group OPM holds ≥ 26% for FY7/26 with KPI table for Internal BizReach.
- Buyback authorization ≥ ¥10bn over 24 months or formula-based return policy.
- BizReach revenue ≥ +15% YoY through any domestic hiring dip.
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion. JII does not have an investment opinion on any security discussed.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Conflicts & positions. JII may provide paid IR diagnostic, translation, or interpretation services to Japanese listed companies, including companies discussed in this publication. JII does not trade in or hold positions in the securities of companies profiled. Where a JII engagement exists with a profiled company, that fact will be disclosed at the top of the profile.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。